Komori
Changes in Officers2395SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.Information and Communications, Services and Others

Changes in Representative Directors and Executive Appointments

Nagata Ryoichi (永田良一), currently Representative Director, Chairman and President, will become Representative Director and Chairman, while Hirama Hideyuki (平間英之) is scheduled to become Representative Director and President. There will also be changes involving the candidates for Director, Executive Officers and Corporate Officers.

Worth reading
47Recurring
Scored from 4 of 5 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
1
Increase in the number of Directors
Wording
Conditional
How definitive the wording is.

Who is moving to which position

Resolved 30 April 2026

Incoming appointee

3 items
Scheduled Appointment DateEffective 26 June 2026 (the appointments of Directors will be formally decided subject to their election at the General Meeting of Shareholders scheduled for 26 June 2026)
Hirama Hideyuki (平間 英之)
Previous position— (position as of 30 April 2026)
New positionRepresentative Director and President
Umehara Tomoki (梅原 友樹)
Previous positionExecutive Officer, General Manager of the Power Generation Business Division and Head of the President's Office
New positionDirector, Head of Asset Management, General Manager of the Power Generation Business Division and Head of the Chairman's Office
Nishie Kento (西江 賢人)
Previous positionSenior General Manager of the Finance Control Division, Corporate Strategy Headquarters, and Financial Controller (Chief)
New positionExecutive Officer, Senior General Manager of the Finance Control Division, Corporate Strategy Headquarters, and Financial Controller
Date of birthHirama Hideyuki (平間 英之): 15 April 1977. Umehara Tomoki (梅原 友樹) and Nishie Kento (西江 賢人): Not disclosed
Year joined the companyHirama Hideyuki (平間 英之): 2004. Umehara Tomoki (梅原 友樹) and Nishie Kento (西江 賢人): Not disclosed
Number of shares heldHirama Hideyuki (平間 英之): 3,100 shares (record date: Not disclosed). Umehara Tomoki (梅原 友樹) and Nishie Kento (西江 賢人): Not disclosed
Because the names and counts do not correspond, they are shown as reported without linking the counts to individual names.

Departing officer

2 items
Nagata Ryoichi (永田 良一)Next role stated
Former PositionRepresentative Director, Chairman and President
New positionRepresentative director and chairman
Tsuhara Naohiro (津原 直浩)Next role stated
Former PositionExecutive Officer and Deputy Senior General Manager of the Finance Control Division
New positionCorporate Officer and Deputy Senior General Manager of the Finance Control Division

“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.

Whether the incumbent will remain in office (whether they will retain their position)

Nagata Ryoichi (永田良一) will remain on the Board of Directors as Representative Director and Chairman. Tsuhara Naohiro (津原直浩) will change from Executive Officer to Corporate Officer.

Directors after the change14Number
Shareholders’ meeting approvalRequired. Proposal: Election of Directors; scheduled date: 26 June 2026
Reason for change

In anticipation of the Company's next stage of growth, we have decided to appoint a new Representative Director and President in order to further strengthen the management structure and promote sustained growth in corporate value over the medium to long term.

Who is moving to which position
ItemDetails
Resolution date30 April 2026
Scheduled Appointment DateEffective 26 June 2026 (the appointments of Directors will be formally decided subject to their election at the General Meeting of Shareholders scheduled for 26 June 2026)
Name of appointeeHirama Hideyuki (平間 英之), Umehara Tomoki (梅原 友樹), Nishie Kento (西江 賢人)
Appointee's new positionRepresentative Director and President, Director, Head of Asset Management, General Manager of the Power Generation Business Division and Head of the Chairman's Office, Executive Officer, Senior General Manager of the Finance Control Division, Corporate Strategy Headquarters, and Financial Controller
Appointee's previous position— (position as of 30 April 2026), Executive Officer, General Manager of the Power Generation Business Division and Head of the President's Office, Senior General Manager of the Finance Control Division, Corporate Strategy Headquarters, and Financial Controller (Chief)
Appointee's date of birthHirama Hideyuki (平間 英之): 15 April 1977. Umehara Tomoki (梅原 友樹) and Nishie Kento (西江 賢人): Not disclosed
Year the appointee joined the CompanyHirama Hideyuki (平間 英之): 2004. Umehara Tomoki (梅原 友樹) and Nishie Kento (西江 賢人): Not disclosed
Number of shares held by the appointeeHirama Hideyuki (平間 英之): 3,100 shares (record date: Not disclosed). Umehara Tomoki (梅原 友樹) and Nishie Kento (西江 賢人): Not disclosed
Name of departing officerNagata Ryoichi (永田 良一), Tsuhara Naohiro (津原 直浩)
Former position of departing officerRepresentative Director, Chairman and President, Executive Officer and Deputy Senior General Manager of the Finance Control Division
New position of departing officerRepresentative director and chairman, Corporate Officer and Deputy Senior General Manager of the Finance Control Division
Whether the incumbent will remain in officeNagata Ryoichi (永田良一) will remain on the Board of Directors as Representative Director and Chairman. Tsuhara Naohiro (津原直浩) will change from Executive Officer to Corporate Officer.
Reason for changeIn anticipation of the Company's next stage of growth, we have decided to appoint a new Representative Director and President in order to further strengthen the management structure and promote sustained growth in corporate value over the medium to long term.
Number of directors after the change14, including outside Directors: Not disclosed
Subject to Approval by the General Meeting of ShareholdersRequired. Proposal: Election of Directors; scheduled date: 26 June 2026
Items this document does not state (6)
Date of departureReason for departureReasons for appointmentFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

In anticipation of the Company's next stage of growth, we have decided to appoint a new Representative Director and President in order to further strengthen the management structure and promote sustained growth in corporate value over the medium to long term.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Changes in Representative Directors and Executive Appointments | SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. (2395) timely disclosure | Komori